Registration - Consultant

Apotex Inc. / Christopher Froggatt, Consultant

Registration Information

Client name: Apotex Inc.
Lobbyist name: Christopher Froggatt, Consultant
Initial registration start date: 2020-10-30
Registration status: Active
Registration Number: 916365-367794

Associated Communications

Total Number of Communication Reports: 1

Monthly communication reports in the last 6 months: 1

Version 2 of 2 (2024-05-16 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Economic Development, Health	Working with the government on an open and inclusive regulatory regime for generic pharmaceuticals that continues to allow the industry to grow in Canada, and discuss with the government how Apotex can work with them to ensure the security and increase the self-sufficiency of Canada’s drug supply, how the government can help ensure access to international markets, and how the government can utilize generic and biosimilar medications to make pharmacare and other drug programs more sustainable.	Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Infrastructure Canada (INFC)
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Safety Canada (PS)
Public Services and Procurement Canada (PSPC)
Transport Canada (TC)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
200 Barmac Drive
Toronto, ON M9L 2S8
Canada

Telephone number: 416-401-7530

Client representative

Chris Fournier, Vice President, Market Access and Government Relations

Parent Company Information

Apotex Inc. is not a subsidiary of any other parent companies.

Coalition Members Information

Apotex Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Apotex Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Apotex Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Christopher Froggatt | Designated public offices held

Business address:
81 Metcalfe Street, 2nd Floor
Ottawa, ON K1P 6K7
Canada

Telephone number: 613-233-1699

Consultant Firm and Address

Firm: Loyalist Public Affairs

Address:
8 York Street Suite 200
Ottawa, ON K1N 5S6
Canada

Telephone number: 613-218-9545

Apotex Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Apotex Inc./	2024-05-16	current
Apotex Inc./	2020-10-30	2021-09-28

Apotex Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Christopher Froggatt, Loyalist Public Affairs (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-1 of 1

Apotex Inc.
Consultant: Christopher Froggatt

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau , Associate Assistant Deputy Minister | Health Canada (HC)
- Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health
Communication date: 2024-05-31
Posted date: 2024-06-15
Communication number: 367794-605639 View associated registration

Christopher Froggatt, Loyalist Public Affairs (Consultant)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-1 of 1

Apotex Inc.
Consultant: Christopher Froggatt

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau , Associate Assistant Deputy Minister | Health Canada (HC)
- Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)
Subject Matter of the communication: Economic Development, Health
Communication date: 2024-05-31
Posted date: 2024-06-15
Communication number: 367794-605639 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Chief of Staff Transport Canada, Minister's Office	October 2008 to August 2010	August 1, 2010
Chief of Staff Environment Canada, Minister's Office	January 2007 to October 2008	October 29, 2008

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Chief of Staff Transport Canada, Minister's Office	October 2008 to August 2010	August 1, 2010
Chief of Staff Environment Canada, Minister's Office	January 2007 to October 2008	October 29, 2008

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Apotex Inc. / Christopher Froggatt, Consultant

Registration Information

Associated Communications

Version 2 of 2 (2024-05-16 to present)

Version 2 of 2 (2024-05-16 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address